MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: GTCbio - Biopharmaceutical Conference
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Michael Naso, Janssen to Present at Antibody & Protein Therapeutics Manufacturing on October 24-25 in San Diego, California - Michael Naso, Associate Director at Janssen R&D, will give a presentation titled “The Amazing Biology of the Cell: New Biological Concepts Leading to Novel Therapeutic Opportunities”
Michael Naso, Janssen to Present at Antibody & Protein Therapeutics Manufacturing on October 24-25 in San Diego, California

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/09/30 - Michael Naso, Associate Director at Janssen R&D, will give a presentation titled “The Amazing Biology of the Cell: New Biological Concepts Leading to Novel Therapeutic Opportunities”.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Michael Naso, Associate Director at Janssen R&D, will give a presentation titled “The Amazing Biology of the Cell: New Biological Concepts Leading to Novel Therapeutic Opportunities” at GTC’s Antibody & Protein Therapeutics Conference on October 24 25, 2013 in San Diego, CA

In his presentation, Dr. Naso will explain how cells are extremely dynamic entities, with many activities on-going at the same time that define the homeostatic cellular state. If perturbed, there can be rapid alterations to these activities with changes in gene expression that accompany fluctuations in chromatin structure in a dynamic nucleus. As a result of this dynamic complexity, there is a poor understanding of what drives cellular biology. The plasma cell membrane represents the main communication point between the cell and the external environment, possessing a diverse array of different protein receptors and accessory proteins that allow the cell to adjust to any changes presented to it externally. However, it just is being learned that there are many different ways these receptors transmit their signals inside the cell and how the cell integrates these signals to generate the cellular response. This response can be beneficial to the organism, or, detrimental, and result in disease. Recent advances in antibody generation technologies, along with high content screening are allowing us to generate unique antibody biological modulators that can be used to interrogate this complex cellular biology. This will allow for the identification of highly specific molecules that can alter cell biology in very precise ways, leading to new classes of therapeutics.
Michael Naso, Ph.D. is an Associate Director at Janssen Research and Development of Johnson and Johnson. He leads the Target Biology group within the Biologics Research department in the Biotechnology Center of Excellence. The focus of his group is to identify and validate novel targets, pathways and mechanisms for therapeutic intervention, and the discovery of antibody modulators for lead identification. Michael’s team supports all therapeutic areas within Janssen R&D, and has helped bring numerous lead candidates forward for early development. Michael received his Ph.D. from Thomas Jefferson University in Philadelphia, PA, in the department of Biochemistry and Molecular Biology, and has been with Johnson and Johnson for over 12 years.

The Antibody & Protein Therapeutics Conference strives to connect representatives from big pharma, academic institutions and government research labs to present data and case studies on key topics such as antibody drug conjugates, bispecific antibodies and overcoming the blood-brain barrier. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Michael Naso, Janssen to Present at Antibody & Protein Therapeutics Manufacturing on October 24-25 in San Diego, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer
Stevanato Group, SCHOTT, and Gerresheimer Confirm the Readiness to Support Future Covid-19 Vaccine with Pharmaceutical Containers
Ipsen Receives FDA Fast Track Designation for Liposomal Irinotecan (ONIVYDE®) as A First-line Combination Treatment for Metastatic Pancreatic Cancer
Ipsen Demonstrates Continued Commitment to Rare Diseases with Eight Abstracts Accepted At ENDO 2020 Published in the Journal of the Endocrine Society
Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)